American Shared Hospital Services splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Direct Patient Services at $15.5 million, 55% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
30
|
28
|
28
|
21
|
20
|
18
|
18
|
21
|
19
|
—
|
—
|
| Direct Patient Services |
—
|
16
+23.7%
share 55.3%
|
13
+253.4%
share 44.3%
|
4
+14.9%
share 16.7%
|
3
share 15.7%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Domestic |
—
|
—
|
—
|
—
|
—
|
15
-9.2%
share 83.5%
|
16
share 90.8%
|
—
|
—
|
—
|
—
|
| Medical Equipment Leasing |
—
|
13
-20.5%
share 44.7%
|
16
-11.2%
share 55.7%
|
18
+6.7%
share 83.3%
|
17
share 84.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Foreign |
—
|
—
|
—
|
—
|
—
|
3
+78.1%
share 16.5%
|
2
share 9.2%
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- AMS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 744825
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.